FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer

Detalles Bibliográficos
Autores principales: Cervantes, A., Prager, G.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Pro and Con Discussions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976207/
https://www.ncbi.nlm.nih.gov/pubmed/36812740
http://dx.doi.org/10.1016/j.esmoop.2023.100883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976207/
https://www.ncbi.nlm.nih.gov/pubmed/36812740
http://dx.doi.org/10.1016/j.esmoop.2023.100883

Ejemplares similares